BACKGROUND: American cutaneous leishmaniasis is characterized by single or multiple ulcerations. Cytokines, among other factors, have been shown to influence lesion development and tumoral necrosis factor-alpha is a major cytokine implicated in pathogenesis of ulcers. OBSERVATIONS: We tested oral pentoxifylline, a known tumoral necrosis factor-alpha inhibitor, at doses of 400 mg (2-3x/day), associated to N-methylglucamine antimoniate (15 mg/kg/day) in two patients with American cutaneous leishmaniasis unresponsive to antimonial drugs. We observed a satisfactory response with quick cure of skin lesions of these patients. CONCLUSIONS: Our results suggest that oral pentoxifylline in association to N-methylglucamine antimoniate should be consider in refractory cutaneous leishmaniasis patients.
BACKGROUND: American cutaneous leishmaniasis is characterized by single or multiple ulcerations. Cytokines, among other factors, have been shown to influence lesion development and tumoral necrosis factor-alpha is a major cytokine implicated in pathogenesis of ulcers. OBSERVATIONS: We tested oral pentoxifylline, a known tumoral necrosis factor-alpha inhibitor, at doses of 400 mg (2-3x/day), associated to N-methylglucamine antimoniate (15 mg/kg/day) in two patients with American cutaneous leishmaniasis unresponsive to antimonial drugs. We observed a satisfactory response with quick cure of skin lesions of these patients. CONCLUSIONS: Our results suggest that oral pentoxifylline in association to N-methylglucamine antimoniate should be consider in refractory cutaneous leishmaniasispatients.
Authors: Graça Brito; Mayra Dourado; Luiz Henrique Guimarães; Everson Meireles; Albert Schriefer; Edgar Marcelino de Carvalho; Paulo Roberto Lima Machado Journal: Am J Trop Med Hyg Date: 2017-05 Impact factor: 2.345
Authors: Fabiano Oliveira; Andre Bafica; Andrea B Rosato; Cecilia B F Favali; Jackson M Costa; Virginia Cafe; Manoel Barral-Netto; Aldina Barral Journal: Am J Trop Med Hyg Date: 2011-07 Impact factor: 2.345
Authors: Sara Passos; Lucas P Carvalho; Rúbia S Costa; Taís M Campos; Fernanda O Novais; Andréa Magalhães; Paulo R L Machado; Daniel Beiting; David Mosser; Edgar M Carvalho; Phillip Scott Journal: J Infect Dis Date: 2014-08-19 Impact factor: 5.226
Authors: Alon Unger; Seth O'Neal; Paulo R L Machado; Luiz H Guimarães; Daniel J Morgan; Albert Schriefer; Olívia Bacellar; Marshall J Glesby; Edgar M Carvalho Journal: Am J Trop Med Hyg Date: 2009-04 Impact factor: 2.345
Authors: Claudia Gonzalez-Lombana; Ciara Gimblet; Olivia Bacellar; Walker W Oliveira; Sara Passos; Lucas P Carvalho; Michael Goldschmidt; Edgar M Carvalho; Phillip Scott Journal: PLoS Pathog Date: 2013-03-21 Impact factor: 6.823
Authors: Ciara Gimblet; Michael A Loesche; Lucas Carvalho; Edgar M Carvalho; Elizabeth A Grice; David Artis; Phillip Scott Journal: PLoS One Date: 2015-08-18 Impact factor: 3.240